IDRA‑21
Experimental memory-boosting compound: improved learning in rodents and monkeys, never studied in humans.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Pharmacology
Contents
DETAILED OVERVIEW
What is IDRA-21?
IDRA-21 is an experimental compound that has been studied in animals for improving learning and memory. It has not been approved as a medicine anywhere and was never cleared for human use; it exists only as an unregulated research chemical, not intended for human consumption.
It strengthens the signal of glutamate, one of the brain's main stimulating messengers: it slows the process by which the receiving receptor quickly stops responding, so communication between nerve cells can become stronger and longer-lasting. In rodents and monkeys it improved learning and memory, and the effect in monkeys lasted a long time. It has not been studied in humans, so there is practically no data on its safety or long-term effects. In theory it could cause anxiety, restlessness, sleep problems and headache, persistent overstimulation might damage nerve cells, and in people with epilepsy it could raise the risk of seizures. Safety in pregnancy and breastfeeding has not been established.
Mechanism
AMPA-PAM (slows desensitization)
Evidence
Preclinical only (no human data)
Legal status
Unapproved research chemical
No anecdote collected yet.
Receptor profile
- AMPA receptorsStrong
- Long-term potentiation (LTP)Strong
- NMDA receptors (indirect, AMPA-coupled)Moderate
Safety
Side effects, stop signs, contraindications
Side effects · 6
- No human safety data: only preclinical (rodent and primate) studies exist; the compound has never been tested in humans
- Possible glutamatergic overstimulation (anxiety, restlessness, insomnia) inherent to AMPA-positive modulation
- Theoretical excitotoxicity risk at high doses from the sustained AMPA current
- Possible headache typical of the ampakine and racetam class
- Unknown long-term safety and incomplete toxicity profile in humans
- Bell-shaped (inverted-U) dose-response observed in animals: more is not better and may abolish the effect
Contraindications · 4
- Pregnancy and breastfeeding: safety not established, avoid
- Epilepsy or lowered seizure threshold: AMPA potentiation may theoretically increase seizure risk
- Avoid combining with other glutamatergic/stimulant agents due to excitotoxicity risk
- Not an approved medicine; experimental research chemical, not recommended without clinical supervision
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating AMPA receptor desensitization
Zivkovic I, Thompson DM, Bertolino M, Uzunov D, DiBella M, Costa E
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys
Thompson DM, Guidotti A, DiBella M, Costa E
Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices
Arai A, Guidotti A, Costa E, Lynch G
IDRA-21, a positive AMPA receptor modulator, inhibits synaptic and extrasynaptic NMDA receptor mediated events in cultured cerebellar granule cells
Losi G, Puia G, Braghiroli D, Baraldi M
The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques
Malkova L, Kozikowski AP, Gale K
FAQ
FAQ
IDRA-21 is an experimental research compound that has been studied in animals for its effects on learning and memory. The idea behind it is that it prolongs the action of one of the brain's main excitatory signaling chemicals, making communication between neurons stronger and longer-lasting. It's important to note there's essentially no human experience with it, everything known so far comes from rodent and primate studies.
Telegram
Have a question about IDRA‑21?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
